US reopens consultation on lowering neuro devices classification
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has reopened until 7 September the public comment period for its proposal to lower the classification of certain neurological and physical medicine devices from Class III (high-risk) to Class II (medium-risk).